#hematology

All-Oral Therapy Improves Outcomes for Older AML Patients

According to a study published by Medicine, an all-oral treatment regimen combining decitabine–cedazuridine and venetoclax demonstrates viability as a therapeutic option for older or medically ineligible patients with newly diagnosed AML. The…...